Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 3
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment.
Ecke TH, Voß PC, Schlomm T, Rabien A, Friedersdorff F, Barski D, Otto T, Waldner M, Veltrup E, Linden F, Hake R, Eidt S, Roggisch J, Heidenreich A, Rieger C, Kastner L, Hallmann S, Koch S, Wirtz RM. Ecke TH, et al. Among authors: rieger c. Int J Mol Sci. 2022 Jul 18;23(14):7898. doi: 10.3390/ijms23147898. Int J Mol Sci. 2022. PMID: 35887247 Free PMC article.
Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter Study.
Sigle A, Borkowetz A, von Hardenberg J, Drerup M, Kornienko K, Kwe J, Wenzel M, Mandel P, Westhoff N, Rieger C, Hoffmann MA, Ortner G, Mahjoub S; GeSRU Academics Prostate Cancer Group. Sigle A, et al. Among authors: rieger c. Eur Urol Focus. 2023 Jul;9(4):606-613. doi: 10.1016/j.euf.2023.01.020. Epub 2023 Feb 17. Eur Urol Focus. 2023. PMID: 36804191